TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 5 filers reported holding TRANSENTERIX INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,000 | -93.9% | 12,200 | -87.4% | 0.00% | -87.5% |
| Q2 2019 | $132,000 | -56.6% | 97,178 | -23.9% | 0.01% | -52.9% |
| Q1 2019 | $304,000 | +26.1% | 127,710 | +20.0% | 0.02% | +30.8% |
| Q4 2018 | $241,000 | -31.9% | 106,441 | +74.2% | 0.01% | -40.9% |
| Q3 2018 | $354,000 | +490.0% | 61,097 | +73.1% | 0.02% | +633.3% |
| Q1 2018 | $60,000 | -45.0% | 35,288 | -37.5% | 0.00% | -50.0% |
| Q4 2017 | $109,000 | – | 56,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |